Neurology. 2020 Apr 2. pii: 10.1212/WNL.0000000000009507. doi: 10.1212/WNL.0000000000009507. [Epub ahead of print]
Brownlee W, Bourdette D, Broadley S, Killestein J, Ciccarelli O.
The emergence of novel Coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to Neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).